Oligomers incorporating the tetrapeptide MSH4, the minimum active sequence of melanocyte stimulating hormone, were synthesized by an A + B strategy involving microwave-assisted copper-catalyzed azide-alkyne cycloaddition. A contained an MSH4 core while B contained a (Pro-Gly) spacer. Soluble mixtures containing compounds with up to eight MSH4 units were obtained from oligomerizations at high monomer concentrations. The avidities of several oligomeric mixtures were evaluated by means of a competitive binding assay using HEK293 cells engineered to overexpress the melanocortin 4 receptor. When based on total MSH4 concentrations, avidities were only minimally enhanced compared with a monovalent control. The lack of variation in the effect of ligands on probe binding is consistent with high off rates for MSH4 in both monovalent and oligomeric constructs relative to that of the competing probe.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480789 | PMC |
| http://dx.doi.org/10.1016/j.tetlet.2014.12.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease.
bioRxiv
December 2024
Center for Iron Disorders, Department of Medicine, David Geffen School of Medicine at UCLA Los Angeles, CA 90095-1690.
Anemia is a common and disabling complication of chronic kidney disease (CKD). Current therapies can be burdensome, and full correction of anemia is limited by cardiovascular side effects. New approaches that may offer additional therapeutic options are needed.
View Article and Find Full Text PDFNanobodies' duo facilitates ultrasensitive serum HER-2/neu immunoassays via enhanced avidity interactions.
Anal Chim Acta
January 2025
Interdisciplinary Nanoscience Center (iNANO), Faculty of Natural Sciences, Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark. Electronic address:
Background: Existing liquid biopsy assays for protein biomarkers of cancer are mostly based on antibodies (Ab) contributing unfavorably to their high cost. Easy to express and modify in vitro, nanobodies may be a cost-effective alternative to Ab.
Results: We show that serum HER-2/neu, a biomarker and target of aggressive HER-2/neu(+) cancers, can be accurately detected in a 1.
KMT5C leverages disorder to optimize cooperation with HP1 for heterochromatin retention.
EMBO Rep
January 2025
Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.
A defining feature of constitutive heterochromatin compartments is the heterochromatin protein-1 (HP1) family, whose members display fast internal mobility and rapid exchange with the surrounding nucleoplasm. Here, we describe a paradoxical state for the lysine methyltransferase KMT5C characterized by rapid internal diffusion but minimal nucleoplasmic exchange. This retentive behavior is conferred by sparse sequence features that constitute two modules tethered by an intrinsically disordered linker.
View Article and Find Full Text PDFAdaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
Cell
November 2024
Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:
Pathogens constantly evolve and can develop mutations that evade host immunity and treatment. Addressing these escape mechanisms requires targeting evolutionarily conserved vulnerabilities, as mutations in these regions often impose fitness costs. We introduce adaptive multi-epitope targeting with enhanced avidity (AMETA), a modular and multivalent nanobody platform that conjugates potent bispecific nanobodies to a human immunoglobulin M (IgM) scaffold.
View Article and Find Full Text PDFNatriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
JACC Heart Fail
January 2025
Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Article Synopsis
- N-terminal pro-B-type natriuretic peptides (NT-proBNPs) are important biomarkers for evaluating heart failure risk, but their levels can be misleading in patients with chronic kidney disease due to the kidney’s impact on eGFR.
- This study aimed to analyze the relationship between NT-proBNP levels and cardiovascular outcomes, specifically hospitalizations and deaths, in heart failure patients with varying kidney function.
- In a large cohort of over 14,000 patients, the results indicated that NT-proBNP levels significantly increased with lower eGFR levels, and every doubling of NT-proBNP was linked to a 37% higher risk of adverse cardiovascular outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!